Last reviewed · How we verify
NCT07045012
The Relationship Between Osteoporosis and Sarcopenia Parameters in Postmenopausal Women Under 60
trial in Osteoporosis in 52 participants. Not yet recruiting.
25 July 2025
Quick facts
| Lead sponsor | Beylikduzu State Hospital |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 52 |
| Start date | 25 June 2025 |
| Primary completion | 25 July 2025 |
| Estimated completion | 25 July 2025 |
Conditions studied
- Osteoporosis — all drugs for Osteoporosis →
Sponsor
Beylikduzu State Hospital
Who can join
Adults 50 to 59, female only, with Osteoporosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This cross-sectional study will include postmenopausal women under the age of 60 who visited the Physical Medicine and Rehabilitation outpatient clinic at Beylikdüzü State Hospital between June 25 and July 25, 2025. Participants must have undergone a bone mineral density (BMD) assessment within the past six months using Dual X-ray Absorptiometry (DXA). Both osteoporotic and non-osteoporotic patients will be enrolled. Sociodemographic data such as age, height, weight, and BMI will be recorded. Femoral neck and L1-L4 T-scores and BMD values will be obtained from existing DXA results. Information on osteoporosis treatment, presence of fecal incontinence, constipation, and medication use will be collected. In the second phase, sarcopenia will be assessed according to EWGSOP2 criteria using bioelectrical impedance analysis for skeletal muscle mass, handgrip strength, and the five-time sit-to-stand test. Differences between the osteoporotic and non-osteoporotic groups will be analyzed.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07045012
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Osteoporosis
Currently open trials in the same condition.
- NCT07027306 — The Osteoporotic Fracture Classification-based Scoring System for Treatment Decision in Thoracolumbar Osteoporotic Fract · recruiting
- NCT07367776 — Patient Education in Osteoporosis (RCT-PATOS) · NA · recruiting
- NCT06731608 — OsteoPorotic fracTure preventION System (OPTIONS) Research Study · NA · recruiting
- NCT07281586 — Step-down Therapy After Long-term Osteoporosis Treatment · Phase 4 · recruiting
- NCT07083557 — Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiome · recruiting
Other Beylikduzu State Hospital trials
Trials by the same sponsor.
- NCT07044986 — Ultrasonographic Evaluation of the Ulnar Nerve in Individuals With and Without Generalized Joint Hypermobility · not yet recruiting
- NCT07044999 — Evaluation of Balance and Physical Performance Under Dual Task Conditions in Individuals With and Without Generalized Jo · not yet recruiting
- NCT06947200 — Orthorexia Nervosa in Fibromyalgia · recruiting
- NCT06947213 — Orthorexia Nervosa in Postmenopausal Osteoporosis · recruiting
- NCT07238777 — MRI-Based Paraspinal Fatty Degeneration and Its Association With BMD and Sarcopenia · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07045012 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Beylikduzu State Hospital
- Last refreshed: 1 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07045012.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing